Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Biotechnology Media, Sera and Reagents Market by Type (Media, Sera, and Reagent), Application (Cancer Research, Biopharmaceuticals, Clinical Diagnostics, Regenerative Medicine & Tissue Engineering, Others), and End User (Biotechnology & Pharmaceutical Industry, Academic Institute, Research Laboratory, and Others): Global Opportunity Analysis and Industry Forecast, 2018 - 2025

  • ALL2954211
  • 240 Pages
  • March 2019
  • Pharmaceuticals
Download Sample    Get Discount   
 

Biotechnology Media, Sera And Reagents Market Overview:

The global biotechnology media, sera and reagents market was valued at $18,794 million in 2017 and is estimated to reach at $32,974 million by 2025, registering a CAGR of 7.3% from 2018 to 2025.

Biotechnology is the branch of science that uses living organisms to make technological advancements and adapt those technologies to various different fields including agriculture, genetic engineering, novel drug developments, and several others. Media and sera find their application in animal tissue culture and plant tissue culture, while reagents are used in various biotechnology applications such as diagnosis, laboratory research, drug development, and others. 

Considerable rise in the biotechnological R&D pertaining to the development of biopharmaceuticals has led to an increase in demand for culture media, sera, and reagents market. Moreover, increase in investments and funding for research interventions in both developed and developing countries further boost the market growth. However, ethical & scientific concerns associated with the potential of misuse of biotechnology research practices and dearth of skilled personnel restrict the market growth. On the contrary, untapped potential of the emerging economies is anticipated to provide lucrative opportunities to the key players involved in the biotechnology media, sera and reagents market in the near future.

The biotechnology media, sera and reagents media market is segmented based on type, application, end user, and region. Based on type, the market is divided into media, sera and reagents. The media segment is further bifurcated into lysogeny broth, classical media, serum free media, chemically defined media, specialty media, stem cell media and others. The sera segment is further classified into fetal bovine sera, new born calf sera, and others. Likewise, the reagents segment is further segmented into antibiotics, DNA/RNS isolation reagents, PCR reagents, buffers and others. Based on application, the market is categorized into cancer research, biopharmaceuticals, clinical diagnostics, regenerative medicine & tissue engineering, and others. Based on end user, it is classified into biotechnology & pharmaceutical industry, academic institute, research laboratory, and others. Based on region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Benefits for Biotechnology Media, Sera And Reagents Market:

  • The study provides an in-depth analysis of the global biotechnology media, sera and reagents market along with the current trends and future estimations to elucidate the imminent investment pockets.
  • A comprehensive analysis of the factors that drive and restrict the market growth is provided.
  • A comprehensive quantitative analysis of the industry is provided from 2018 to 2025 to assist stakeholders to capitalize on the prevailing market opportunities.
  • An extensive analysis of the key segments of the industry helps understand the global trends in the biotechnology media, sera and reagents market.
  • Key players and their strategies are provided to understand the competitive outlook of the industry.

Biotechnology Media, Sera And Reagents Key Market Segments:

By Type

  • Media

    • Lysogeny Broth
    • Classical Media
    • Serum Free Media
    • Chemically Defined Media
    • Specialty Media
    • Stem Cell Media
    • Others

  • Sera

    • Fetal Bovine Sera
    • New Born Calf Sera
    • Others

  • Reagents

    • Antibiotics
    • DNA/RNS Isolation Reagents
    • PCR Reagents
    • Buffers
    • Others

By Application

  • Cancer Research
  • Biopharmaceuticals
  • Regenerative Medicine & Tissue Engineering
  • Others

By End User

  • Biotechnology & Pharmaceutical Companies
  • Academic Institute
  • Research Laboratory
  • Others

By Region

  • North America

    • U.S.
    • Canada
    • Mexico

  • Europe

    • UK
    • France
    • Germany
    • Italy
    • France
    • Rest of Europe

  • Asia-Pacific

    • Japan
    • China
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific

  • LAMEA 

    • Saudi Arabia
    • South Africa
    • Brazil
    • Rest of LAMEA

Key Market Players

  • GE Healthcare
  • Bio-Rad Laboratories Inc.
  • Merck KGaA (Sigma Aldrich)
  • Sartorius AG
  • HiMedia Laboratories Pvt., Ltd
  • Lonza Group Ltd
  • Merck & Co., Inc.
  • Thermofisher Scientific
  • Corning Incorporated 
  • Becton, Dickinson and Company

The other players in the value chain include (profiles not included in the report)

  • Avantor Performance Materials, LLC
  • Caisson Laboratories, Inc
  • Cell Culture Technologies LLC
  • Fujifilm Holdings Corporation
  • Sera Scandia A/S (Biowest)
  • Vitro Diagnostics, Inc.
  • Cyagen Biosciences

CHAPTER 1: INTRODUCTION

1.1. Report description

1.2. Key benefits for stakeholders

1.3. Key market segments

1.3.1. List of key players profiled in the report

1.4. Research methodology

1.4.1. Secondary research

1.4.2. Primary research

1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. Key findings of the study

2.1.1. CXO perspective

CHAPTER 3: MARKET OVERVIEW

3.1. Market definition and scope

3.2. Key findings

3.2.1. Top investment pockets

3.2.2. Top winning strategies

3.3. Market share analysis, 2017

3.4. Market dynamics

3.4.1. Drivers

3.4.1.1. Rise in R&D Investment

3.4.1.2. Increase in advancements associated with cell culture media

3.4.1.3. High demand for media, sera and reagents

3.4.2. Restraints

3.4.2.1. Dearth of skilled professionals

3.4.2.2. Ethical & scientific concerns associated with culture media

3.4.3. Opportunity

3.4.3.1. Untapped potential of the emerging economies

CHAPTER 4: BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY TYPE

4.1. Overview

4.1.1. Market size and forecast

4.2. Media

4.2.1. Key market trends and opportunity

4.2.2. Market size and forecast, by region

4.2.3. Market analysis, by country

4.2.4. Lysogeny broth

4.2.4.1. Market size and forecast

4.2.5. Chemically defined media

4.2.5.1. Market size and forecast

4.2.6. Classical media

4.2.6.1. Market size and forecast

4.2.7. Serum-free Media

4.2.7.1. Market size and forecast

4.2.8. Specialty media

4.2.8.1. Market size and forecast

4.2.9. Stem cell media

4.2.9.1. Market size and forecast

4.2.10. Other media

4.2.10.1. Market size and forecast

4.3. Sera

4.3.1. Key market trends and opportunity

4.3.1.1. Market size and forecast

4.3.3. Market analysis, by country

4.3.4. Fetal Bovine Sera Market

4.3.4.1. Market size and forecast

4.3.5. New Born Calf Sera

4.3.5.1. Market size and forecast

4.3.6. others

4.3.6.1. Market size and forecast

4.4. Reagent

4.4.1. Key market trends and opportunity

4.4.1.1. Market size and forecast

4.4.2. Market analysis, by country

4.4.3. Antibiotics

4.4.3.1. Market size and forecast

4.4.4. DNA/RNA Isolation Reagents

4.4.4.1. Market size and forecast

4.4.5. PCR Reagents

4.4.5.1. Market size and forecast

4.4.6. Buffers

4.4.6.1. Market size and forecast

4.4.7. Other reagents

4.4.7.1. Market size and forecast

CHAPTER 5: BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET BY APPLICATION

5.1. Overview

5.1.1. Market size and forecast

5.2. Cancer research

5.2.1. Market size and forecast, by region

5.2.2. Market analysis, by country

5.3. Biopharmaceuticals

5.3.1. Market size and forecast, by region

5.3.2. Market analysis, by country

5.4. Regenerative medicine & tissue engineering

5.4.1. Market size and forecast, by region

5.4.2. Market analysis, by country

5.5. Other Applications

5.5.1. Market size and forecast, by region

5.5.2. Market analysis, by country

CHAPTER 6: BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY END USER

6.1. Overview

6.1.1. Market size and forecast

6.2. Biotechnology & pharmaceutical industry

6.2.1. Market size and forecast, by region

6.2.2. Market analysis, by country

6.3. Academic institute

6.3.1. Market size and forecast, by region

6.3.2. Market analysis, by country

6.4. Research laboratory

6.4.1. Market size and forecast, by region

6.4.2. Market analysis, by country

CHAPTER 7: BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY REGION

7.1. Overview

7.1.1. Market size and forecast

7.2. North America

7.2.1. Key market trends and opportunities

7.2.2. North America biotechnology media, sera and reagents market size and forecast, by country

7.2.2.1. U.S. market size and forecast, by type

7.2.2.2. U.S. market size and forecast, by application

7.2.2.3. U.S. biotechnology media, sera and reagents market, by end user

7.2.2.4. Canada market size and forecast, by type

7.2.2.5. Canada biotechnology media, sera and reagents market, by application

7.2.2.6. Canada biotechnology media, sera and reagents market, by end user

7.2.2.7. Mexico biotechnology media, sera and reagents market, by type

7.2.2.8. Mexico biotechnology media, sera and reagents market, by application

7.2.2.9. Mexico biotechnology media, sera and reagents market, by end user

7.2.3. North America biotechnology media, sera and reagents market size and forecast, by type

7.2.4. North America biotechnology media, sera and reagents market size and forecast, by application

7.2.5. North America biotechnology media, sera and reagents market size and forecast, by end user

7.3. Europe

7.3.1. Key market trends

7.3.2. Europe biotechnology media, sera and reagents market size and forecast, by country

7.3.2.1. Germany market size and forecast, by type

7.3.2.2. Germany biotechnology media, sera and reagents market, by application

7.3.2.3. Germany biotechnology media, sera and reagents market, by end user

7.3.2.4. France market size and forecast, by type

7.3.2.5. France biotechnology media, sera and reagents market, by application

7.3.2.6. France biotechnology media, sera and reagents market, by end user

7.3.2.7. UK market size and forecast, by type

7.3.2.8. UK biotechnology media, sera and reagents market, by application

7.3.2.9. UK biotechnology media, sera and reagents market, by end user

7.3.2.10. Italy market size and forecast, by type

7.3.2.11. Italy biotechnology media, sera and reagents market, by application

7.3.2.12. Italy biotechnology media, sera and reagents market, by end user

7.3.2.13. Spain biotechnology media, sera and reagents market, by type

7.3.2.14. Spain biotechnology media, sera and reagents market, by application

7.3.2.15. Spain biotechnology media, sera and reagents market, by end user

7.3.2.16. Rest of Europe biotechnology media, sera and reagents market, by type

7.3.2.17. Rest of Europe biotechnology media, sera and reagents market, by application

7.3.2.18. Rest of Europe biotechnology media, sera and reagents market, by end user

7.3.3. Europe biotechnology media, sera and reagents market size and forecast, by type

7.3.4. Europe biotechnology media, sera and reagents market size and forecast, by application

7.3.5. Europe biotechnology media, sera and reagents market size and forecast, by end user

7.4. Asia-Pacific

7.4.1. Key market trends

7.4.2. Asia-Pacific biotechnology media, sera and reagents market size and forecast, by country

7.4.2.1. Japan biotechnology media, sera and reagents market, by type

7.4.2.2. Japan biotechnology media, sera and reagents market, by application

7.4.2.3. Japan biotechnology media, sera and reagents market, by end user

7.4.2.4. China biotechnology media, sera and reagents market, by type

7.4.2.5. China biotechnology media, sera and reagents market, by application

7.4.2.6. China biotechnology media, sera and reagents market, by end user

7.4.2.7. India biotechnology media, sera and reagents market, by type

7.4.2.8. India biotechnology media, sera and reagents market, by application

7.4.2.9. India biotechnology media, sera and reagents market, by end user

7.4.2.10. Australia biotechnology media, sera and reagents market, by type

7.4.2.11. Australia biotechnology media, sera and reagents market, by application

7.4.2.12. Australia biotechnology media, sera and reagents market, by end user

7.4.2.13. South Korea biotechnology media, sera and reagents market, by type

7.4.2.14. South Korea biotechnology media, sera and reagents market, by application

7.4.2.15. South Korea biotechnology media, sera and reagents market, by end user

7.4.2.16. Taiwan biotechnology media, sera and reagents market, by type

7.4.2.17. Taiwan biotechnology media, sera and reagents market, by application

7.4.2.18. Taiwan biotechnology media, sera and reagents market, by end user

7.4.2.19. Rest of Asia-Pacific biotechnology media, sera and reagents market, by type

7.4.2.20. Rest of Asia-Pacific biotechnology media, sera and reagents market, by application

7.4.2.21. Rest of Asia-Pacific biotechnology media, sera and reagents market, by end user

7.4.3. Asia-Pacific biotechnology media, sera and reagents market size and forecast, by type

7.4.4. Asia-Pacific biotechnology media, sera and reagents market size and forecast, by application

7.4.5. Asia-Pacific biotechnology media, sera and reagents market size and forecast, by end user

7.5. LAMEA

7.5.1. Key market trends

7.5.2. LAMEA biotechnology media, sera and reagents market size and forecast, by country

7.5.2.1. Brazil biotechnology media, sera and reagents market, by type

7.5.2.2. Brazil biotechnology media, sera and reagents market, by application

7.5.2.3. Brazil biotechnology media, sera and reagents market, by end user

7.5.2.4. Saudi Arabia biotechnology media, sera and reagents market, by type

7.5.2.5. Saudi Arabia biotechnology media, sera and reagents market, by application

7.5.2.6. Saudi Arabia biotechnology media, sera and reagents market, by end user

7.5.2.7. South Africa biotechnology media, sera and reagents market, by type

7.5.2.8. South Africa biotechnology media, sera and reagents market, by application

7.5.2.9. South Africa biotechnology media, sera and reagents market, by end user

7.5.2.10. Rest of LAMEA biotechnology media, sera and reagents market, by type

7.5.2.11. Rest of LAMEA biotechnology media, sera and reagents market, by application

7.5.2.12. Rest of LAMEA biotechnology media, sera and reagents market, by end user

7.5.3. LAMEA biotechnology media, sera and reagents market size and forecast, by type

7.5.4. LAMEA biotechnology media, sera and reagents market size and forecast, by application

7.5.5. LAMEA biotechnology media, sera and reagents market size and forecast, by end user

CHAPTER 8: COMPANY PROFILES

8.1. Production capacity and facility of key companies

8.2. Becton, Dickinson and Company

8.2.1. Company overview

8.2.2. Company snapshot

8.2.3. Operating business segments

8.2.4. Business performance

8.2.5. Key strategic moves and developments

8.3. Bio-Rad Laboratories Inc.

8.3.1. Company overview

8.3.2. Company snapshot

8.3.3. Operating business segments

8.3.4. Business performance

8.4. Corning Incorporated

8.4.1. Company overview

8.4.2. Company snapshot

8.4.3. Operating business segments

8.4.4. Business performance

8.5. GE Healthcare

8.5.1. Company overview

8.5.2. Company snapshot

8.5.3. Operating business segments

8.5.4. Business performance

8.5.5. Key strategic moves and developments

8.6. HiMedia Laboratories Pvt., Ltd

8.6.1. Company overview

8.6.2. Company snapshot

8.6.3. Operating business segments

8.6.4. Key strategic moves and developments

8.7. Lonza Group Ltd

8.7.1. Company overview

8.7.2. Company snapshot

8.7.3. Operating business segments

8.7.4. Business performance

8.7.5. Key strategic moves and developments

8.8. Merck & Co., Inc.

8.8.1. Company overview

8.8.2. Company snapshot

8.8.3. Operating business segments

8.8.4. Product portfolio

8.8.5. Key strategic moves and developments

8.9. Sartorius AG

8.9.1. Company overview

8.9.2. Company snapshot

8.9.3. Operating business segments

8.9.4. Business performance

8.9.5. Key strategic moves and developments

8.10. Thermo Fisher Scientific Inc.

8.10.1. Company overview

8.10.2. Company snapshot

8.10.3. Operating business segments

8.10.4. Business performance

8.10.5. Key strategic moves and developments

LIST OF TABLES

TABLE 01. GLOBAL BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKETBY TYPE, 20172025 ($MILLION)

TABLE 02. BIOTECHNOLOGY MEDIA MARKET, BY REGION, 20172025 ($MILLION)

TABLE 01. LYSOGENY BROTH CULTURE MEDIA MARKET, BY REGION, 2017-2025 ($MILLION)

TABLE 02. CHEMICALLY DEFINED CULTURE MEDIA MARKET, BY REGION, 2017-2025 ($MILLION)

TABLE 03. CLASSICAL CULTURE MEDIA MARKET, BY REGION, 2017 2025 ($MILLION)

TABLE 04. SERUM-FREE CULTURE MEDIA MARKET, BY REGION, 2017-2025 ($MILLION)

TABLE 05. SPECIALTY CULTURE MEDIA MARKET, BY REGION, 20172025 ($MILLION)

TABLE 06. STEM CELL CULTURE MEDIA MARKET, BY REGION, 20172025 ($MILLION)

TABLE 07. OTHER CULTURE MEDIA MARKET, BY REGION, 20172025 ($MILLION)

TABLE 08. BIOTECHNOLOGY SERA MARKET, BY REGION, 20172025 ($MILLION)

TABLE 09. BIOTECHNOLOGY FETAL BOVINE SERA MARKET, BY REGION, 20172025 ($MILLION)

TABLE 10. BIOTECHNOLOGY NEW BORN CALF SERA MARKET, BY REGION, 20172025 ($MILLION)

TABLE 11. BIOTECHNOLOGY FETAL BOVINE SERA MARKET, BY REGION, 20172025 ($MILLION)

TABLE 12. BIOTECHNOLOGY REAGENTS MARKET, BY REGION, 2017-2025 ($MILLION)

TABLE 13. BIOTECHNOLOGY REAGENTS MARKET, FOR ANTIBIOTICS BY REGION, 20172025 ($MILLION)

TABLE 14. BIOTECHNOLOGY REAGENTS MARKET, FOR DNA/RNA ISOLATION REAGENTS BY REGION, 20172025 ($MILLION)

TABLE 15. BIOTECHNOLOGY REAGENTS MARKET, FOR PCR REAGENTS BY REGION, 20172025 ($MILLION)

TABLE 16. BIOTECHNOLOGY REAGENTS MARKET, FOR BUFFERS BY REGION, 20172025 ($MILLION)

TABLE 17. BIOTECHNOLOGY REAGENTS MARKET, FOR OTHER REAGENTS BY REGION, 20172025 ($MILLION)

TABLE 18. GLOBAL BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET REVENUE, BY APPLICATION, 20172025 ($MILLION)

TABLE 19. BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET FOR CANCER RESEARCH, BY REGION, 20172025 ($MILLION)

TABLE 20. BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET FOR BIOPHARMACEUTICALS, BY REGION, 20172025 ($MILLION)

TABLE 21. BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET FOR REGENERATIVE MEDICINE & TISSUE ENGINEERING, BY REGION, 20172025 ($MILLION)

TABLE 22. BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET FOR OTHER APPLICATIONS, BY REGION, 20162023 ($MILLION)

TABLE 23. GLOBAL BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET REVENUE, BY END USER, 20172025($MILLION)

TABLE 24. BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET FOR BIOTECHNOLOGY & PHARMACEUTICAL INDUSTRY, BY REGION, 20172025 ($MILLION)

TABLE 25. BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET FOR ACADEMIC INSTITUTE, BY REGION, 20172025($MILLION)

TABLE 26. BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET FOR RESEARCH LABORATORY, BY REGION, 20172025($MILLION)

TABLE 27. BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET REVENUE, BY REGION, 20172025($MILLION)

TABLE 28. NORTH AMERICA BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY COUNTRY, 20172025($MILLION)

TABLE 29. U.S. BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY TYPE, 20172025($MILLION)

TABLE 30. U.S. BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY APPLICATION, 20172025($MILLION)

TABLE 31. U.S. BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY END USER, 20172025($MILLION)

TABLE 32. CANADA BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY TYPE, 20172025($MILLION)

TABLE 33. CANADA BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY APPLICATION, 20172025($MILLION)

TABLE 34. CANADA BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY END USER, 20172025($MILLION)

TABLE 35. MEXICO BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY TYPE, 20172025($MILLION)

TABLE 36. MEXICO BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY APPLICATION, 20172025($MILLION)

TABLE 37. MEXICO BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY END USER, 20172025($MILLION)

TABLE 38. NORTH AMERICA BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY TYPE, 20172025($MILLION)

TABLE 39. NORTH AMERICA BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY APPLICATION, 20172025($MILLION)

TABLE 40. EUROPE BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY END USER, 20172025($MILLION)

TABLE 41. EUROPE BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY COUNTRY, 20172025($MILLION)

TABLE 42. GERMANY BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY TYPE, 20172025($MILLION)

TABLE 43. GERMANY BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY APPLICATION, 20172025($MILLION)

TABLE 44. GERMANY BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY END USER, 20172025($MILLION)

TABLE 45. FRANCE BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY TYPE, 20172025($MILLION)

TABLE 46. FRANCE BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY APPLICATION, 20172025($MILLION)

TABLE 47. FRANCE BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY END USER, 20172025($MILLION)

TABLE 48. UK BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY TYPE, 20172025($MILLION)

TABLE 49. UK BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY APPLICATION, 20172025($MILLION)

TABLE 50. UK BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY END USER, 20172025($MILLION)

TABLE 51. ITALY BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY TYPE, 20172025($MILLION)

TABLE 52. ITALY BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY APPLICATION, 20172025($MILLION)

TABLE 53. ITALY BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY END USER, 20172025($MILLION)

TABLE 54. SPAIN BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY TYPE, 20172025($MILLION)

TABLE 55. SPAIN BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY APPLICATION, 20172025($MILLION)

TABLE 56. SPAIN BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY END USER, 20172025($MILLION)

TABLE 57. REST OF EUROPE BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY TYPE, 20172025($MILLION)

TABLE 58. REST OF EUROPE BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY APPLICATION, 20172025($MILLION)

TABLE 59. REST OF EUROPE BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY END USER, 20172025($MILLION)

TABLE 60. EUROPE BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY TYPE, 20172025($MILLION)

TABLE 61. EUROPE BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY APPLICATION, 20172025($MILLION)

TABLE 62. EUROPE BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY END USER, 20172025($MILLION)

TABLE 63. ASIA-PACIFIC BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY COUNTRY, 20172025($MILLION)

TABLE 64. JAPAN BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY TYPE, 20172025($MILLION)

TABLE 65. JAPAN BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY APPLICATION, 20172025($MILLION)

TABLE 66. JAPAN BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY END USER, 20172025($MILLION)

TABLE 67. CHINA BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY TYPE, 20172025($MILLION)

TABLE 68. CHINA BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY APPLICATION, 20172025($MILLION)

TABLE 69. CHINA BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY END USER, 20172025($MILLION)

TABLE 70. INDIA BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY TYPE, 20172025($MILLION)

TABLE 71. INDIA BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY APPLICATION, 20172025($MILLION)

TABLE 72. INDIA BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY END USER, 20172025($MILLION)

TABLE 73. AUSTRALIA BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY TYPE, 20172025($MILLION)

TABLE 74. AUSTRALIA BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY APPLICATION, 20172025($MILLION)

TABLE 75. AUSTRALIA BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY END USER, 20172025($MILLION)

TABLE 76. SOUTH KOREA BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY TYPE, 20172025($MILLION)

TABLE 77. SOUTH KOREA BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY APPLICATION, 20172025($MILLION)

TABLE 78. SOUTH KOREA BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY END USER, 20172025($MILLION)

TABLE 79. TAIWAN BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY TYPE, 20172025($MILLION)

TABLE 80. TAIWAN BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY APPLICATION, 20172025($MILLION)

TABLE 81. TAIWAN BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY END USER, 20172025($MILLION)

TABLE 82. REST OF ASIA-PACIFIC BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY TYPE, 20172025($MILLION)

TABLE 83. REST OF ASIA-PACIFIC BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY APPLICATION, 20172025($MILLION)

TABLE 84. REST OF ASIA-PACIFIC BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY END USER, 20172025($MILLION)

TABLE 85. ASIA-PACIFIC BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY TYPE, 20172025($MILLION)

TABLE 86. ASIA-PACIFIC BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY APPLICATION, 20172025($MILLION)

TABLE 87. ASIA-PACIFIC BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY END USER, 20172025($MILLION)

TABLE 88. LAMEA BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY COUNTRY, 20172025($MILLION)

TABLE 89. BRAZIL BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY TYPE, 20172025($MILLION)

TABLE 90. BRAZIL BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY APPLICATION, 20172025($MILLION)

TABLE 91. BRAZIL BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY END USER, 20172025($MILLION)

TABLE 92. SAUDI ARABIA BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY TYPE, 20172025($MILLION)

TABLE 93. SAUDI ARABIA BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY APPLICATION, 20172025($MILLION)

TABLE 94. SAUDI ARABIA BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY END USER, 20172025($MILLION)

TABLE 95. SOUTH AFRICA BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY TYPE, 20172025($MILLION)

TABLE 96. SOUTH AFRICA BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY APPLICATION, 20172025($MILLION)

TABLE 97. SOUTH AFRICA BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY END USER, 20172025($MILLION)

TABLE 98. REST OF LAMEA BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY TYPE, 20172025($MILLION)

TABLE 99. REST OF LAMEA BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY APPLICATION, 20172025($MILLION)

TABLE 100. REST OF LAMEA BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY END USER, 20172025($MILLION)

TABLE 101. LAMEA BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY TYPE, 20172025($MILLION)

TABLE 102. LAMEA BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY APPLICATION, 20172025($MILLION)

TABLE 103. LAMEA BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY END USER, 20172025($MILLION)

TABLE 104. PRODUCTION CAPACITY AND FACILITY OF KEY PLAYERS: BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, 2018

TABLE 105. BD: COMPANY SNAPSHOT

TABLE 106. BD: OPERATING SEGMENTS

TABLE 107. BIO-RAD: COMPANY SNAPSHOT

TABLE 108. BIO-RAD: OPERATING SEGMENTS

TABLE 109. CORNING: COMPANY SNAPSHOT

TABLE 110. CORNING: OPERATING SEGMENTS

TABLE 111. GE HEALTHCARE: COMPANY SNAPSHOT

TABLE 112. GE HEALTHCARE: OPERATING SEGMENTS

TABLE 113. HIMEDIA: COMPANY SNAPSHOT

TABLE 114. HIMEDIA: OPERATING SEGMENTS

TABLE 115. LONZA: COMPANY SNAPSHOT

TABLE 116. LONZA: OPERATING SEGMENTS

TABLE 117. MERCK: COMPANY SNAPSHOT

TABLE 118. MERCK: OPERATING SEGMENTS

TABLE 119. MERK: PRODUCT PORTFOLIO

TABLE 120. SARTORIUS: COMPANY SNAPSHOT

TABLE 121. SARTORIUS: OPERATING SEGMENTS

TABLE 122. THERMO FISHER: COMPANY SNAPSHOT

TABLE 123. THERMO FISHER: OPERATING SEGMENTS

LIST OF FIGURES

FIGURE 01. BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET SEGMENTATION

FIGURE 02. TOP INVESTMENT POCKETS

FIGURE 03. TOP WINNING STRATEGIES, BY YEAR, 20152018*

FIGURE 04. TOP WINNING STRATEGIES, BY DEVELOPMENT, 20152018*

FIGURE 05. TOP WINNING STRATEGIES, BY COMPANY, 20152018*

FIGURE 06. MARKET SHARE ANALYSIS, 2017

FIGURE 07. COMPARATIVE COUNTRY ANALYSIS OF BIOTECHNOLOGY MEDIA MARKET, 2017 AND 2025 ($MILLION)

FIGURE 08. COMPARATIVE COUNTRY ANALYSIS OF BIOTECHNOLOGY SERA MARKET, 2017 AND 2025 ($MILLION)

FIGURE 09. COMPARATIVE COUNTRY ANALYSIS OF BIOTECHNOLOGY REAGENTS MARKET, 2017 AND 2025 ($MILLION)

FIGURE 10. COMPARATIVE COUNTRY ANALYSIS OF BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET FOR CANCER RESEARCH, 2017 AND 2025 ($MILLION)

FIGURE 11. COMPARATIVE COUNTRY ANALYSIS OF BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET FOR BIOPHARMACEUTICALS, 2017 AND 2025 ($MILLION)

FIGURE 12. COMPARATIVE COUNTRY ANALYSIS OF BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET FOR REGENERATIVE MEDICINE & TISSUE ENGINEERING, 2017 AND 2025 ($MILLION)

FIGURE 13. COMPARATIVE COUNTRY ANALYSIS OF BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET FOR OTHER APPLICATIONS, 2017 AND 2025 ($MILLION)

FIGURE 14. COMPARATIVE COUNTRY ANALYSIS OF BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET FOR BIOTECHNOLOGY & PHARMACEUTICAL INDUSTRY, 2017 AND 2025 ($MILLION)

FIGURE 15. COMPARATIVE COUNTRY ANALYSIS OF BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET FOR ACADEMIC INSTITUTE, 2017 AND 2025 ($MILLION)

FIGURE 16. COMPARATIVE COUNTRY ANALYSIS OF BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET FOR RESEARCH LABORATORY, 2017 AND 2025 ($MILLION)

FIGURE 17. BD: NET SALES, 20152017 ($MILLION)

FIGURE 18. BD: REVENUE SHARE BY SEGMENT, 2017 (%)

FIGURE 19. BD: REVENUE SHARE BY GEOGRAPHY, 2017 (%)

FIGURE 20. BIO-RAD: NET SALES, 20152017 ($MILLION)

FIGURE 21. BIO-RAD: REVENUE SHARE BY SEGMENT, 2017 (%)

FIGURE 22. BIO-RAD: REVENUE SHARE BY GEOGRAPHY, 2017 (%)

FIGURE 23. CORNING: NET SALES, 20152017 ($MILLION)

FIGURE 24. CORNING: REVENUE SHARE BY SEGMENT, 2017 (%)

FIGURE 25. CORNING: REVENUE SHARE BY GEOGRAPHY, 2017 (%)

FIGURE 26. GE HEALTHCARE: NET SALES, 20152017 ($MILLION)

FIGURE 27. GE HEALTHCARE: REVENUE SHARE BY SEGMENT, 2017 (%)

FIGURE 28. GE HEALTHCARE: REVENUE SHARE BY GEOGRAPHY, 2017 (%)

FIGURE 29. LONZA: NET SALES, 20152017 ($MILLION)

FIGURE 30. LONZA: REVENUE SHARE BY SEGMENT, 2017 (%)

FIGURE 31. MERCK: NET SALES, 20152016 ($MILLION)

FIGURE 32. MERCK: REVENUE SHARE BY SEGMENT, 2017 (%)

FIGURE 33. MERCK: REVENUE SHARE BY GEOGRAPHY, 2017 (%)

FIGURE 34. SARTORIUS: NET SALES, 20152017 ($MILLION)

FIGURE 35. SARTORIUS: REVENUE SHARE BY SEGMENT, 2017 (%)

FIGURE 36. SARTORIUS: REVENUE SHARE BY GEOGRAPHY, 2017(%)

FIGURE 37. THERMO FISHER: NET SALES, 20152017 ($MILLION)

FIGURE 38. THERMO FISHER: REVENUE SHARE BY SEGMENT, 2017 (%)

FIGURE 39. THERMO FISHER: REVENUE SHARE BY GEOGRAPHY, 2017 (%)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

Protein Therapeutics Market by Product (Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, and Follicle Stimulating Hormone) and Application (Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...

  • Publish Date: November 14, 2017
  • $5370
Global Cord Blood Banking Services (Stem Cell) Market, Size, Share, Trends, Forecast, Global Analysis, Research, Report, Segmentation, and Future Demand, 2012 - 2020

Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...

  • Publish Date: July 20, 2017
  • $5370